Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era

Liver Transplantation

Volumn 10, Issue 10 SUPPL. 2, 2004, Pages

  Mandell, M Susan ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN; PROSTAGLANDIN; VASODILATOR AGENT;

ARTICLE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG ARTERY; LUNG ARTERY PRESSURE; MEDICAL DECISION MAKING; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESOURCE ALLOCATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASODILATATION;

DECISION SUPPORT TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; HEPATOPULMONARY SYNDROME; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, STATISTICAL; PROGNOSIS;

EID: 6444227185     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20260     Document Type: Article

References (31)

1. Krowka M, Cortese D. Hepatopulmonary syndrome: current concepts in diagnosis and therapeutic considerations. Chest 1994;105:1528-1537.
2. Van Thiel D, Schade R, Gavaler J, Shaw B, Iwatsuki S, Starzl T. Medical aspects of liver transplantation. Hepatology 1984; 4(Suppl):79-83.
3. United Network for Organ Sharing. Policy 3.6.5.4.1 Liver candidates with hepatopulmonary syndrome. Available at http://www.unos.org/policiesandbylaws/policies/doc. Accessed April 27, 2004.
4. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-1052.
5. Lange P, Stoller J. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521-529.
6. Taille C, Cadrand J, Bellocq A, Thabut G, Soubrane O, Durand F, et al. Liver transplantation for hepatopulmonary syndrome. A ten-year experience in Paris, France. Transplantation 2003;75:1482-1489.
7. Castro M, Krowka M. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med 1996;17:35-48.
8. Lange P, Stoller J. The hepatopulmonary syndrome. Ann Intern Med 1995;122:521-529.
9. Abrams GA, Nanda NC, Dubovsky EV, Krowka M J, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998;114:305-310.
10. Agusti A, Roca J, Rodriguez-Roizen R. Mechanisms of gas exchange impairment in patients with liver cirrhosis. Clin Chest Med 1996;17:49-66
11. Arguedas M, Abrams G, Krowka M, Fallon M. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003;37:192-197.
12. Scientific Registry of Transplant Recipients. Transplant statistics; national report. Available at http://www.ustransplant.org/crs_0104/national.php. Accessed April 27, 2004.
13. Krowka M J, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest 2000;118:615-624.
14. Egawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, Fujita S, et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999;67:712-717.
15. Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004;10:174-182.
16. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krona RA. Pulmonary hemodynamics and perioperarive cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000;6:443-450.
17. Mandell M, Krowka M. National database for hepatopulmonary syndrome and portopulmonary hypertension in liver transplant candidates / recipients. Anesthesiology 1997;87:450 451.
18. Cotton C, Gandhi S, Vaitkus P, Massad M, Benedetti E, Mrtek R, Wiley T. Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl 2002;8:1051-1054.
19. Kim W, Krowka M, Plevak D, Lee J, Rettke S, Frantz R, Wiesner R. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl 2000;6:453-458.
20. Colle I, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003;37:401-409.
21. Mandell M, Durham J, Kumpe D, Trotter JF, Everson G, Niemann C. The effects of desflurane and propofol on portosystemic pressure in patients with portal hypertension. Anesth Analg 2003;97:1573-1577.
22. Robalino BD, Moodie DS. Primary pulmonary hypertension, then and now: 28 years of experience. Cleve Clin J Med 1992; 59:411-417
23. Ramsay M, Simpson B, Nguyen A, Ramsay K, East C, Klintmalm G. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 1997;3:494-500.
24. Starkel P, Vera A, Gunson B, Mutimer D. Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl 2002;8:382-388.
25. Koneru B, Ahmed S, Weisse A, Grant G, McKim K. Resolution of pulmonary hypertension of cirrhosis after liver transplantation. Transplantation 1994;58:1133-1135.
26. Rafanan A, Maurer J, Mehta A, Schilz R. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol. Chest 2000;118:1497-1500.
27. Koneru B, Fisher A, Wilson D, Klein K, dela Torre A, Seguel J. De novo diagnosis of portopulmonary hypertension following liver transplantation. Am J Transplant 2002;2:883-886.
28. Mandell M, Groves B, Duke J. Progressive plexogenic pulmonary hypertension following liver transplantation. Transplantation 1995;59:1488-1490.
29. Kuo P, Johnson L, Plotkin J, Howell C, Bartlett S, Rubin L. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997;63:604-606.
30. Plotkin J, Kuo P, Rubin L, Gaine S, Howell C, Laurin J, et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 1998;65:457-459.
31. Krowka M. Editorial: pulmonary hypertension, (high) risk of orthotopic liver transplantation, and some lessons from " primary" pulmonary hypertension. Liver Transpl 2002;8:389-390.